Chemed Corporation (NYSE:CHE) Receives Average Rating of “Hold” from Analysts

Shares of Chemed Corporation (NYSE:CHE) have earned a consensus rating of “Hold” from the six research firms that are presently covering the company, MarketBeat.com reports. Five analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $530.75.

Several research firms recently commented on CHE. Wall Street Zen upgraded shares of Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. Bank of America restated a “neutral” rating on shares of Chemed in a report on Wednesday, July 29th. Royal Bank Of Canada upped their price objective on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research report on Thursday, July 30th. Weiss Ratings upgraded shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. Finally, Oppenheimer lifted their target price on Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a research report on Friday, July 31st.

Insider Buying and Selling

In other news, Director Patrick P. Grace sold 190 shares of the business’s stock in a transaction on Friday, July 31st. The shares were sold at an average price of $532.00, for a total value of $101,080.00. Following the sale, the director owned 3,533 shares in the company, valued at approximately $1,879,556. The trade was a 5.10% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Andrea R. Lindell sold 1,347 shares of the company’s stock in a transaction dated Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the sale, the director directly owned 4,578 shares in the company, valued at approximately $2,047,876.74. The trade was a 22.73% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 6,537 shares of company stock valued at $3,406,014. 3.33% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Chemed

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CHE. Monetary Solutions Ltd acquired a new stake in shares of Chemed during the fourth quarter worth approximately $25,000. Los Angeles Capital Management LLC acquired a new position in shares of Chemed in the 4th quarter worth approximately $26,000. BOK Financial Private Wealth Inc. acquired a new position in shares of Chemed in the 4th quarter worth approximately $27,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in Chemed during the 2nd quarter worth approximately $34,000. Finally, Versant Capital Management Inc grew its position in Chemed by 7,500.0% during the 2nd quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock worth $35,000 after acquiring an additional 75 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Chemed Stock Up 0.0%

Chemed stock opened at $523.57 on Monday. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89. Chemed has a fifty-two week low of $365.20 and a fifty-two week high of $557.00. The firm has a fifty day moving average price of $509.45 and a two-hundred day moving average price of $449.68. The firm has a market cap of $6.84 billion, a price-to-earnings ratio of 26.30, a P/E/G ratio of 1.98 and a beta of 0.51.

Chemed (NYSE:CHE) last announced its earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, beating the consensus estimate of $5.60 by $0.46. The firm had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The firm’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, analysts forecast that Chemed will post 23.18 earnings per share for the current year.

Chemed Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be given a dividend of $0.70 per share. This is a boost from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date is Monday, August 17th. This represents a $2.80 annualized dividend and a dividend yield of 0.5%. Chemed’s dividend payout ratio is 14.06%.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.